Sicor Inc.

The Irvine pharmaceutical company reported that net income for the first quarter rose to $11.9 million, or 11 cents a share, from $3.6 million, or 4 cents a share, for the first quarter of 2000. A pretax charge of $3.5 million was recorded in the first quarter of 2001 related to the impairment of certain assets associated with the company’s Italian operations. In the first quarter of 2000, a special charge of $2.9 million related to an accounting change was recorded. Revenue increased 23% to $84.2 million.